IT

Fabio Macciardi

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabio Macciardi. Retrieved from https://idiyas.com/inventor/fabio-macciardi-stsa7esy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Fabio Macciardi: Innovator in Pharmacogenomics

Introduction

Fabio Macciardi is a notable inventor in the field of pharmacogenomics, focusing on the genetic factors that influence individual responses to medications. His work aims to enhance treatment strategies for cardiovascular conditions through personalized medicine.

Latest Patents

Fabio Macciardi has developed a patent titled "Methods And Systems For Pharmacogenomic Treatment Of Cardiovascular Conditions." This patent outlines methods and systems that leverage genetic variations to optimize the efficacy of rostafuroxin in patients. The invention emphasizes the role of specific polymorphisms in genes such as KCNS3, THSD7A, FAM46A, LOC389970, HLA-G, and TTC29, which can significantly affect treatment outcomes.

Career Highlights

Macciardi is currently associated with Cvie Therapeutics Limited, where he contributes to advancing therapeutic solutions based on genetic insights. His innovative approach aims to bridge the gap between genetics and effective treatment protocols.

Collaborations

Some of his notable coworkers include Giuseppe Bianchi and Patrizia Ferrari, who collaborate with him in research and development efforts at Cvie Therapeutics Limited.

Conclusion

Fabio Macciardi's contributions to pharmacogenomics represent a significant advancement in personalized medicine, particularly for cardiovascular treatments. His work continues to pave the way for more effective and tailored therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…